Kuva Labs Acquisition of Lisata Therapeutics Signals Major Shift in Oncology Drug Development
In a move that caught many industry analysts by surprise this week, Kuva Labs announced a definitive agreement to acquire Lisata Therapeutics.
by 
Josh Weiner
Josh Weiner